Riskpilot← Back to searchSign inGet full accessORL-INSTITUTE AS
ASActiveOrg 916903820Bulrats Vei 7, 8020 BodøGeneral medical practice activities · NACE 8621Est. 20166 employees
Revenue 2024
NOK 8,9M
+13% vs 2023
EBITDA margin
35.7%
+48% vs 2023
Equity ratio
82.0%
Financial strength
Net profit 2024
NOK 2,1M
+71% vs 2023
| Revenue | NOK 8,9M | +13% |
| EBITDA | NOK 3,2M | +48% |
| Net profit | NOK 2,1M | +71% |
| Total assets | NOK 6,9M | +44% |
| Equity | NOK 5,7M | +50% |
| Employees | 6 | — |
Legal name
ORL-INSTITUTE AS
Org number
916903820
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
16. mars 2016
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i aksjer, eiendom samt drive legevirksomhet.
Address
Bulrats Vei 7, 8020 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 008 | 6 422 | 6 824 | 7 827 | 8 869 |
| Staff expenses | −1 428 | −3 125 | −3 938 | −3 936 | −4 054 |
| EBITDA | −183 | 1 862 | 1 572 | 2 133 | 3 167 |
| Depreciation & amort. | −15 | −311 | −488 | −496 | −458 |
| EBIT | −198 | 1 552 | 1 084 | 1 636 | 2 709 |
| Net financials | −0 | 0 | −479 | −32 | 28 |
| Profit before tax | −199 | 1 552 | 605 | 1 605 | 2 736 |
| Tax | −0 | 298 | 238 | 360 | 606 |
| Net profit | −199 | 1 254 | 367 | 1 244 | 2 130 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 088 | 5 655 | 6 022 | 4 822 | 6 948 |
| Equity | 944 | 2 198 | 2 565 | 3 809 | 5 695 |
| Long-term debt | 682 | 2 571 | 2 574 | 74 | 46 |
| Short-term debt | 462 | 886 | 884 | 938 | 1 206 |
| Total debt | 1 144 | 3 457 | 3 457 | 1 013 | 1 252 |
EBITDA margin
35.7%
This company
15.8%
Market median
+126% vs market
20202024
Equity ratio
82.0%
This company
38.2%
Market median
+115% vs market
20202024
Return on equity
37.4%
This company
18.4%
Market median
+103% vs market
20202024
Net profit margin
24.0%
This company
8.1%
Market median
+196% vs market
20202024
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORL-INSTITUTE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Turid Tveraabak | Board of Directors | 0 companies |
| Jørgen Tveraabak | Chairman | 0 companies |
| Anna Maria Parente Ribes | Board of Directors | 0 companies |